Company Filing History:
2 out of 119 
1 out of 378 
Years Active: 2020-2024
Title: Innovator Spotlight: Eva-Maria Gutierrez
Introduction
Eva-Maria Gutierrez is a prominent inventor based in Illertissen, Germany, known for her impactful contributions to the field of biotechnology. With a total of three patents to her name, her work primarily focuses on the development of antibodies that target human CEACAM6, a critical molecule in cancer treatment.
Latest Patents
Among her latest innovations is the patent for "Anti-CEACAM6 antibodies and uses thereof." This invention provides recombinant antigen-binding regions and antibodies that are specific to human CEACAM6 (Carcinoembryonic antigen-related cell adhesion molecule 6). The technology ensures minimal cross-reactivity with closely related CEACAM family members, allowing for targeted cancer therapy. The patent detail includes methods to generate such antibodies, which can be utilized in treating cancer and other disorders associated with CEACAM6 expression. Furthermore, this patent encompasses nucleic acid sequences, vectors, pharmaceutical compositions, and kits complete with instructions for use.
Career Highlights
Eva-Maria Gutierrez's professional journey is marked by her tenure at leading organizations in the biotechnology and pharmaceutical sectors. She has worked at the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and Bayer Pharma Aktiengesellschaft, where she honed her expertise in cancer research and antibody development.
Collaborations
Throughout her career, Eva-Maria has collaborated with notable colleagues, including Jörg Willuda and Uwe Gritzan. These collaborations have undoubtedly enhanced her research capabilities and contributions to the scientific community.
Conclusion
Eva-Maria Gutierrez's innovative work in antibody development showcases her dedication to advancing cancer treatments. Her patents highlight the significance of targeted therapies in improving patient outcomes and underline her role as a key inventor in the biotechnology industry. The impact of her contributions is expected to grow as the field continues to evolve.